Ichiro Hayakawa

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

Yusuke Ogitani, Tetsuo Aida, Katsunobu Hagihara et al. · Clinical Cancer Research · 2016 · 1K citations · Full text

Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents

Masao Yoshida, Ichiro Hayakawa, Noriyuki Hayashi et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 200 citations

Medicinal Chemistry, Potent Antitumor Agents, Medicine +10

A Novel HER3-Targeting Antibody–Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization

Yuuri Hashimoto, Kumiko Koyama, Yasuki Kamai et al. · Clinical Cancer Research · 2019 · 164 citations

Thienopyridine and benzofuran derivatives as potent anti-tumor agents possessing different structure–activity relationships

Ichiro Hayakawa, Rieko Shioya, Toshinori Agatsuma et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 125 citations

Derivative (Chemistry), Benzofuran Derivatives, Potent Anti-tumor Agents +8

4-Hydroxy-3-methyl-6-phenylbenzofuran-2-carboxylic acid ethyl ester derivatives as potent anti-tumor agents

Ichiro Hayakawa, Rieko Shioya, Toshinori Agatsuma et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 104 citations

Medicinal Chemistry, Potent Anti-tumor Agents, Medicine +5